Skip to content

Study · Not a test of the peptide alone · 2013

2 results

Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.

Carr JC, Sherman SK, Wang D, Dahdaleh FS, Bellizzi AM, O'Dorisio MS, O'Dorisio TM, Howe JR

Annals of surgical oncology10 Oct 2013Cited by 17 (Europe PMC)

PMID24114056 (opens in a new tab)PMCIDPMC3981744 (opens in a new tab)DOI10.1245/s10434-013-3318-6 (opens in a new tab)PepBankPUB-24114056
Source linkPubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneObservational studyOther

    In patients with small bowel and pancreatic neuroendocrine tumours, OXTR mRNA was overexpressed in primary and metastatic tumours compared with normal tissue.

    In plain wordsIn tumour samples from patients, the oxytocin receptor gene was more active than in normal tissue. No oxytocin was given.

    Peptide
    Oxytocin
    Outcome
    IncreaseOXTR mRNA expression in primary and metastatic SBNETs and PNETs
    Study

    n: not reported in source

    Comparator
    Normal tissue
    Outcome group
    Receptor activity and mechanism · Cancer

    Source sentences

    Summary
    Compared to normal tissue, the oxytocin receptor (OXTR) showed significant overexpression in both primary and metastatic SBNETs and PNETs.
    1 context sentence
    Summary · context
    Primary SBNETs and PNETs, normal tissue, nodal, and liver metastases were collected and mRNA expression of six target genes was determined by quantitative PCR.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02HumanNot a test of Oxytocin aloneObservational studyOther

    In neuroendocrine tumour samples, OXTR protein expression was confirmed by immunohistochemistry.

    In plain wordsIn tumour samples, the oxytocin receptor protein was found by staining. No oxytocin was given.

    Peptide
    Oxytocin
    Outcome
    IncreaseOXTR protein expression by immunohistochemistry
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Cancer

    Source sentences

    Summary
    OXTR protein expression was confirmed by immunohistochemistry.
    1 context sentence
    Summary · context
    Primary SBNETs and PNETs, normal tissue, nodal, and liver metastases were collected and mRNA expression of six target genes was determined by quantitative PCR.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.